SecSonar.com

Nyxoah S.A. (NYXH)

Nyxoah S.A. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Nyxoah S.A. (NYXH) is a Medical - Instruments & Supplies company based in BE with a market capitalization of $112M. Revenue grew 121.6% year-over-year and free cash flow was negative at -$78.1M. This page tracks NYXH's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

BE · 183 employees · IPO Apr 28, 2021

Valuation

Valuation & price

$3.08 · as of May 17, 2026 · -62.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

2.28

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$8.28$4.81$1.34Jul 25Dec 25Jul 26Jul 7, 25$7.86Jul 9, 25$7.75Jul 11, 25$7.56Jul 15, 25$7.93Jul 17, 25$8.28Jul 21, 25$7.94Jul 23, 25$7.78Jul 25, 25$7.58Jul 29, 25$7.48Jul 31, 25$7.46Aug 4, 25$7.49Aug 6, 25$7.25Aug 11, 25$7.02Aug 13, 25$6.31Aug 15, 25$6.22Aug 19, 25$6.27Aug 21, 25$6.35Aug 25, 25$6.46Aug 27, 25$6.17Aug 29, 25$6.24Sep 3, 25$5.88Sep 5, 25$5.93Sep 9, 25$5.69Sep 11, 25$5.55Sep 16, 25$4.65Sep 18, 25$4.78Sep 22, 25$5.03Sep 24, 25$4.79Sep 26, 25$4.51Sep 30, 25$4.60Oct 2, 25$5.00Oct 6, 25$5.80Oct 8, 25$6.10Oct 10, 25$6.38Oct 14, 25$6.10Oct 16, 25$5.90Oct 21, 25$5.73Oct 23, 25$5.67Oct 27, 25$5.29Oct 29, 25$5.10Oct 31, 25$5.19Nov 4, 25$5.07Nov 6, 25$5.02Nov 10, 25$5.37Nov 12, 25$5.89Nov 14, 25$5.00Nov 18, 25$4.62Nov 20, 25$4.55Nov 25, 25$4.57Nov 28, 25$4.80Dec 2, 25$4.71Dec 4, 25$4.81Dec 8, 25$4.95Dec 10, 25$4.92Dec 12, 25$4.73Dec 16, 25$4.80Dec 18, 25$4.65Dec 22, 25$4.75Dec 24, 25$4.65Dec 29, 25$4.75Jan 2, 26$4.50Jan 6, 26$4.83Jan 8, 26$5.01Jan 12, 26$5.08Jan 14, 26$5.12Jan 16, 26$5.01Jan 21, 26$4.75Jan 23, 26$4.69Jan 27, 26$4.76Jan 29, 26$4.89Feb 2, 26$4.73Feb 4, 26$4.67Feb 9, 26$4.73Feb 11, 26$4.67Feb 13, 26$4.43Feb 18, 26$4.88Feb 20, 26$4.55Feb 24, 26$4.27Feb 26, 26$4.70Mar 2, 26$4.02Mar 4, 26$3.94Mar 6, 26$3.74Mar 10, 26$3.54Mar 12, 26$3.45Mar 17, 26$3.12Mar 19, 26$3.09Mar 23, 26$3.16Mar 25, 26$3.17Mar 27, 26$2.82Mar 31, 26$2.92Apr 2, 26$3.56Apr 7, 26$3.30Apr 9, 26$2.87Apr 13, 26$2.96Apr 15, 26$3.38Apr 17, 26$3.26Apr 22, 26$3.07Apr 24, 26$2.98Apr 28, 26$3.01Apr 30, 26$2.95May 4, 26$2.88May 6, 26$3.22May 8, 26$3.26May 12, 26$3.07May 14, 26$2.92May 18, 26$2.92May 20, 26$2.86May 22, 26$2.87May 28, 26$2.99Jun 1, 26$3.02Jun 3, 26$2.87Jun 5, 26$1.45Jun 9, 26$1.34Jun 11, 26$1.49Jun 15, 26$1.55Jun 17, 26$1.59Jun 22, 26$1.57Jun 24, 26$1.62Jun 26, 26$1.67Jul 2, 26$1.72
$1.3152-week range$8.28
Loading valuation history…

Fundamentals

Key fundamentals

$112M

Market cap

121.6%

Revenue growth (YoY)

63.1%

Gross margin

-$78.1M

Free cash flow (USD)

-$5.9M

Net debt

Net cash position

16.4%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2025

FY 2017$0.00FY 2018$0.00FY 2019$0.00FY 2020$69.0KFY 2021$852.0KFY 2022$3.1MFY 2023$4.3MFY 2024$4.5MFY 2025$10.0M
$0$10M

Free cash flow by year

2017 → 2025

FY 2017$-8.4MFY 2018$-8.2MFY 2019$-11.7MFY 2020$-17.5MFY 2021$-37.2MFY 2022$-45.1MFY 2023$-55.7MFY 2024$-55.3MFY 2025$-68.3M
-$8.4M-$68.3M

Gross margin by year

2021 → 2025

FY 202164.4%FY 202262.7%FY 202361.9%FY 202465.7%FY 202563.1%
64.4%63.1%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 6-K filed May 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingTransparency NotificationsJun 23, 2026Filing
  • 6-K filingShare Issuance UpdateJun 11, 2026Filing
  • 6-K filingUnderwriting AgreementJun 8, 2026Filing
  • 6-K filingCEO Transition AnnouncementJun 4, 2026Filing
  • Quarterly reportQuarterly Report FiledMay 12, 2026Filing

Questions

Frequently asked questions

What is Nyxoah S.A.'s market cap?

Nyxoah S.A. (NYXH) has a market capitalization of $112M.

What is NYXH's P/E ratio?

A meaningful P/E ratio is not available for NYXH — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is NYXH's price-to-book (P/B) ratio?

NYXH trades at 2.28 times book value per share.

Are insiders buying NYXH stock?

SEC Form 4 filings show no open-market insider buys at Nyxoah S.A. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Instruments & Supplies

STSS

Sharps Technology, Inc.

$77.9M

ZTEK

Zentek Ltd.

$63.2M

DXR

Daxor Corporation

$49.3M

POCI

Precision Optics Corporation, Inc.

$42.4M

NEPH

Nephros, Inc.

$40.2M

KRMD

KORU Medical Systems, Inc.

$188.8M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.